Instituto Universitario de Investigación en Neuroquímica
Centre/Institut
![Foto de Ana](/img/nophoto.png)
Ana
González-Pinto Arrillaga
Publicacions en què col·labora amb Ana González-Pinto Arrillaga (23)
2024
-
Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis
Journal of Psychiatric Research, Vol. 172, pp. 334-339
2023
-
Association of Prolactin, Oxytocin, and Homocysteine With the Clinical and Cognitive Features of a First Episode of Psychosis Over a 1-Year Follow-Up
International Journal of Neuropsychopharmacology, Vol. 26, Núm. 11, pp. 796-807
2022
-
Inflammation biomarkers in suicide attempts and their relation to abuse, global functioning and cognition
World Journal of Biological Psychiatry, Vol. 23, Núm. 4, pp. 307-317
-
The Influence of Oxytocin and Prolactin During a First Episode of Psychosis: The Implication of Sex Differences, Clinical Features, and Cognitive Performance
The international journal of neuropsychopharmacology, Vol. 25, Núm. 8, pp. 666-677
-
The role of BDNF and NGF plasma levels in first-episode schizophrenia: A longitudinal study
European Neuropsychopharmacology, Vol. 57, pp. 105-117
2021
-
Gut microbiota, innate immune pathways, and inflammatory control mechanisms in patients with major depressive disorder
Translational Psychiatry, Vol. 11, Núm. 1
2020
2019
-
Association between medication adherence and oxidative stress in patients with first-episode mania
Frontiers in Psychiatry, Vol. 10, Núm. MAR
-
CIBERSAM: Ten years of collaborative translational research in mental disorders
Revista de Psiquiatria y Salud Mental, Vol. 12, Núm. 1, pp. 1-8
-
Differences in the regulation of inflammatory pathways in adolescent- and adult-onset first-episode psychosis
European Child and Adolescent Psychiatry, Vol. 28, Núm. 10, pp. 1395-1405
2018
-
Cardiovascular Risk in Early Psychosis: Relationship with Inflammation and Clinical Features 6 Months after Diagnosis
International Journal of Neuropsychopharmacology, Vol. 21, Núm. 5, pp. 410-422
2016
-
BDNF and NGF Signalling in Early Phases of Psychosis: Relationship with Inflammation and Response to Antipsychotics after 1 Year
Schizophrenia Bulletin, Vol. 42, Núm. 1, pp. 142-151
-
Cognition and psychopathology in first-episode psychosis: Are they related to inflammation?
Psychological Medicine, Vol. 46, Núm. 10, pp. 2133-2144
-
Dysregulated peripheral endocannabinoid system signaling is associated with cognitive deficits in first-episode psychosis
Journal of Psychiatric Research, Vol. 75, pp. 14-21
2015
-
Discrimination between Alzheimer's disease and late onset bipolar disorder using multivariate analysis
Frontiers in Aging Neuroscience, Vol. 7, Núm. DEC
-
Pro-/antiinflammatory dysregulation in early psychosis: Results from a 1-year follow-Up study
International Journal of Neuropsychopharmacology, Vol. 18, Núm. 2, pp. 1-10
2014
-
Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study
Schizophrenia Research, Vol. 156, Núm. 1, pp. 23-29
-
Birth weight, working memory and epigenetic signatures in IGF2 and related genes: A MZ twin study
PLoS ONE, Vol. 9, Núm. 8
-
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: Toward an integrative inflammatory hypothesis of schizophrenia
Schizophrenia Bulletin, Vol. 40, Núm. 2, pp. 376-387
2013
-
Peripheral endocannabinoid system dysregulation in first-episode psychosis
Neuropsychopharmacology, Vol. 38, Núm. 13, pp. 2568-2577